[1] Miller K D, Nogueira L, Mariotto A B, et al. Cancer treatment and survivorship statistics, 2019[J]. CA Cancer J Clin, 2019, 69(5):363-385. [2] 刘红云. 64排螺旋CT三期增强扫描对原发性肝癌的诊断价值分析[J]. 影像研究与医学应用, 2020, 4(24):117-118. [3] 雷婷, 严俊, 袁建涛. 血清GGT、GGT/ALT、甲胎蛋白、异常凝血酶原时间水平在早期原发性肝癌患者中的变化及意义[J]. 中国卫生工程学, 2024, 23(3):354-356. [4] Wang X, Gao J, Zhou B, et al. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles[J]. Life Sci, 2019, 232:116596. [5] Ziogas I A, Sioutas G, Mylonas K S, et al. Role of microRNA in the diagnosis and management of hepatocellular carcinoma[J]. Microrna, 2020, 9(1):25-40. [6] 李乾, 郭清皓. 肝细胞癌中miR-574-5p的表达与作用及其与预后的关系[J]. 中国普通外科杂志, 2021, 30(8):926-933. [7] Liao Z, Zhang H, Su C, et al. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis[J]. J Exp Clin Cancer Res, 2021, 40(1):36. [8] 中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2024年版)[J]. 中国实用外科杂志, 2024, 44(4):361-386. [9] 李小钰, 黄青, 吴雨濛, 等. 2022年全球癌症统计报告的窄谱总结和展望[J]. 肿瘤防治研究, 2024, 51(5):307-312. [10] 高磊磊, 秦帅鑫, 陈威, 等. TACE联合RFA治疗中期原发性肝癌的疗效及对患者血清GP73、AFP和AFP-L3水平的影响[J]. 临床和实验医学杂志, 2021, 20(13):1388-1391. [11] Trandofilov M, Prazdnikov E, Svetashov V, et al. The comparative analysis of the treatment efficacy in patients with primary and secondary cancer of a liver with the use of RFA and MWA[J]. HPB, 2019, 21(3):S903-S904. [12] 李振伟, 赵宏伟, 杜森. 多层螺旋CT联合miR-527,miR-25检测对早期原发性肝癌诊断的临床价值[J]. 中国CT和MRI杂志, 2024, 22(2):105-107. [13] Huang W, Zhao Y, Xu Z, et al. The regulatory mechanism of miR-574-5p expression in cancer[J]. Biomolecules, 2022, 13(1):40. [14] 范瑷霞. 曲马多下调miR-574-5p对胃癌细胞增殖及凋亡的影响机制研究[J]. 河北医药, 2021, 43(7):981-984,989. [15] Li C, Tan F, Pei Q, et al. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis[J]. Cell Prolif, 2019, 52(4):e12632. [16] Terekhanova N V, Karpova A, Liang W W, et al. Epigenetic regulation during cancer transitions across 11 tumour types[J]. Nature, 2023, 623(7986):432-441. [17] Ghoshdastider U, Sendoel A. Exploring the pan-cancer landscape of posttranscriptional regulation[J]. Cell Rep, 2023, 42(10):113172. [18] Sun J, Zhang Y, Li B, et al. PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression[J]. Cell Death Dis, 2019, 10(11):844. [19] Xie W, Xiao J, Wang T, et al. MicroRNA-876-5p inhibits cell proliferation, migration and invasion by targeting c-Met in osteosarcoma[J]. J Cell Mol Med, 2019, 23(5):3293-3301. [20] Yu Z, Chen T, Mo H, et al. BRD8, which is negatively regulated by miR-876-3p, promotes the proliferation and apoptosis resistance of hepatocellular carcinoma cells via KAT5[J]. Arch Biochem Biophys, 2020, 693:108550. [21] 盖雪, 李国华, 付荣, 等. 多层螺旋CT灌注扫描联合血清FABP5、SEMA-3B对老年原发性肝癌的诊断和预后评估价值[J]. 中国老年学杂志, 2023, 43(15):3639-3642. [22] 刘印梅, 秦永建, 郭训田. CT增强扫描联合甲胎蛋白在原发性肝癌患者介入术前诊断及术后疗效评估中的应用价值[J]. 中国卫生工程学, 2022, 21(6):984-986. [23] 蒋会东, 谢强, 李军, 等. 64排CT联合NSE、ProGRP在肺癌鉴别诊断及TNM分期中的应用[J]. 中国现代医学杂志, 2022, 32(14):95-100. |